Zyma

Zyma Pharma is an Egyptian pharmaceutical company established in 2021 through the acquisition of four existing pharmaceutical entities. The company operates as a vertically integrated organization involved in the development, manufacturing, marketing, and distribution of a wide range of healthcare products, including branded generics, nutraceuticals, and cosmeceuticals. Its portfolio covers diverse therapeutic areas such as central nervous system, orthopedics, gynecology, and pediatrics. Zyma Pharma aims to become one of the top 50 pharmaceutical companies in Egypt within five years and is actively expanding its manufacturing capabilities with plans for a dedicated factory. The company focuses on delivering high-quality, affordable healthcare solutions to both domestic and international markets.